病理确诊散发性阿尔茨海默病的发病年龄与APOE相关异质性
该回顾性队列研究分析1750例病理确诊的散发性重度阿尔茨海默病(AD)患者,评估发病年龄、APOE基因型及其交互作用对临床和病理指标的影响。结果显示早发型AD更易表现为非记忆主导的非典型症状,尤其在APOE ε4阴性时,且认知和功能下降更快,但更少合并血管或其他非AD病理。
要点
- 早发型AD更常见非认知行为、运动症状或非记忆认知主诉。
- 早发型AD客观执行功能差但语言损害轻,认知和功能下降更快。
- APOE ε4阴性早发型AD更易被误诊为非AD病理。
核心结论
- 早发型散发性AD更易出现非记忆主导的非典型临床表现,尤其在缺乏APOE ε4等位基因时,可能导致误判为非AD病理。
研究设计与样本
- 回顾性队列研究,纳入1750例病理确诊的散发性重度AD患者,使用回归和混合效应模型分析国家阿尔茨海默病协调中心数据库数据。
主要发现
- APOE ε4阴性病例的发病年龄频率呈双峰分布,最佳分离点为63岁。
- 早发型AD比晚发型AD更易出现非认知行为或运动症状或非记忆认知主诉,客观测试中执行功能障碍更多但语言损害更少。
- 发病年龄和ε4阴性基因型独立关联更低的基线MMSE评分和更重的功能损害。
- 无论APOE基因型如何,早发型AD比晚发型AD的认知和功能下降更快。
- 早发型AD比晚发型AD更易获得非AD临床诊断,尽管更可能为不伴血管或其他非AD神经退行性病理的纯AD。
关键数值与推荐
- 发病年龄频率在APOE ε4阴性病例中呈双峰分布,最佳分离点为63岁。
- 分组:ε4-早发型AD(n=169)、ε4+早发型AD(n=273)、ε4-晚发型AD(n=511)、ε4+晚发型AD(n=797)。
临床怎么用
- 对早发型AD患者应警惕非记忆主导的非典型表现,尤其APOE ε4阴性时,避免误诊为非AD病理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize age-related clinical heterogeneity in Alzheimer disease (AD) and determine whether it is modified by APOE genotype or concomitant non-AD pathology, we analyzed data from 1,750 patients with sporadic, pathologically confirmed severe AD. METHODS: In this retrospective cohort study, regression and mixed effects models assessed effects of estimated age at onset, APOE genotype, and their interaction on standardized clinical, cognitive, and pathologic outcome measures from the National Alzheimer's Coordinating Center database. RESULTS: A bimodal distribution of age at onset frequency in APOE ε4- cases showed best separation at age 63. Using this age cutoff, cases were grouped as ε4- early-onset AD (EOAD) (n = 169), ε4+ EOAD (n = 273), ε4- late-onset AD (LOAD) (n = 511), and ε4+ LOAD (n = 797). Patients with EOAD were more likely than patients with LOAD to present with noncognitive behavioral or motor symptoms or nonmemory cognitive complaints, and had more executive dysfunction, but less language impairment on objective cognitive testing. Age at onset and ε4- genotype were independently associated with lower baseline Mini-Mental State Examination scores and greater functional impairment and patients with EOAD had faster cognitive and functional decline than patients with LOAD regardless of APOE genotype. Patients with EOAD were more likely than patients with LOAD to receive a non-AD clinical diagnosis even though they were more likely to have pure AD without concomitant vascular or other non-AD neurodegenerative pathology. CONCLUSIONS: Early-onset sporadic AD is associated with a greater likelihood of an atypical, non-memory-dominant clinical presentation, especially in the absence of the APOE ε4 allele, which may lead to misattribution to non-AD underlying pathology.
引用
- Smirnov DS, Galasko D, Hiniker A, et al. Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease. Neurology. 2021. PMID: 33722993. doi:10.1212/WNL.0000000000011772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。